Atracurium

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Atracurium is a neuromuscular blocker indicated to relax muscles during mechanical ventilation under general anesthesia or intubation.

Generic Name
Atracurium
DrugBank Accession Number
DB13295
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental, Investigational
Synonyms
Not Available

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
1,2-BenzodiazepineThe risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Atracurium.
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Atracurium.
AcetophenazineThe risk or severity of adverse effects can be increased when Acetophenazine is combined with Atracurium.
AcetyldigitoxinThe risk or severity of Cardiac Arrhythmia can be increased when Atracurium is combined with Acetyldigitoxin.
AclidiniumAtracurium may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Atracurium.
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Atracurium.
AlimemazineThe risk or severity of adverse effects can be increased when Alimemazine is combined with Atracurium.
AlloinThe therapeutic efficacy of Alloin can be decreased when used in combination with Atracurium.
AlmotriptanThe risk or severity of adverse effects can be increased when Almotriptan is combined with Atracurium.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more

Categories

ATC Codes
M03AC04 — Atracurium
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
2GQ1IRY63P
CAS number
64228-79-1
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
  1. TITCK Product Information: Neucurium (atracurium besylate) solution for injection [Link]
RxNav
1218
Wikipedia
Atracurium_besilate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedDiagnosticAtracurium / Cefazolin / Morphine / Nadroparin / Obese1
4CompletedPreventionKidney Diseases / Prostate Hypertrophy1
4CompletedSupportive CarePost Operative Nausea and Vomiting (PONV) / Postoperative pain1
4CompletedSupportive CareQuality of Ocular Akinesia (Onset and Duration)1
4CompletedTreatmentNeuromuscular Blockade / Regional Anesthesia1
4CompletedTreatmentTracheal Intubation1
4Unknown StatusOtherPatients Undergoing Laparoscopic Surgery1
4Unknown StatusTreatmentAnaesthesia therapy1
4Unknown StatusTreatmentMyoclonus1
3CompletedDiagnosticPostoperative pain1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntravenous
SolutionIntravenous50 mg
InjectionIntravenous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on June 23, 2017 20:39 / Updated on June 02, 2021 20:03